Popular Articles

Roll-your-own Cigarettes As Deadly As Ready Mades
Roll-your-own (RYO) cigarettes expose smokers to similar levels of cancer-causing chemicals as manufactured cigarettes according to a new study by Cancer Research UK now published in Addiction Biology *.

Bayer Unveils DIDGET(TM), The First And Only Blood Glucose Meter That Connects With The Nintendo DS(TM) Or DS(TM) Lite
Bayer Diabetes Care in the UK and Ireland today unveils "DIDGET(TM), the
News of the day
Health Care Reform: What Small Business Wants
"As Congress prepares to do battle over health reform, a parallel dispute is shaping up among small-business groups that are staking out opposing positions on a key element of reform proposals: whether Uncle Sam will take on a bigger role in offering insurance coverage or leave the field to the private market," CNN Money reports. A fierce critic of the Clinton administration"s health care reform efforts a decade ago, the [National Federation of Independent Business] now considers universal health care to be one of its top legislative priorities. But it wants to see that care and coverage come from the private sector." The NFIB supports "a reform plan that would provide universal coverage and cut costs by increasing competition among private insurers, likely through the creation of government-mediated insurance pools." But "the Main Street Alliance, founded last year to lobby on behalf of small-business owners around health reform, says its survey of 1,200 small business operators and self-employed entrepreneurs in the 12 states where it operates found that 59% prefer a public option, with only 26% wanting more private plan choices alone" (deMaus, 7/2).
Endocrinology

GenWay Biotech Obtains CLIA Certification

GenWay Biotech, Inc., a US-based diagnostic company has become CLIA certified and received a California lab license. Their license currently permits the testing of immunological biomarkers. This is a very important step in the direction of commercialization of the novel innovative diagnostic tests currently being developed at GenWay. In upcoming weeks, GenWay will add new cancer biomarker tests to their portfolio as well as several infectious diseases such as sexual transmitted diseases. GenWay is seeking to obtain CAP accreditation by the end of the year. Dr. Joe Voland, CLIA Pathologist and lab director, claims that he has never seen a CLIA lab get set up so efficiently and professionally as GenWay has done. GenWay Biotech Inc. is a GMP compliant facility with capabilities for research, development and manufacturing of proteins, antibodies, immunoassays, and diagnostics. Consequently, most quality control and assurance measures were already in place facilitating the transition into a CLIA certified laboratory. Furthermore, GenWay"s lab is under construction for the addition of a Class 10,000 clean room which should be complete sometime in August 2009. Dylan Malayter, Project Manager, who has played a predominant role in guiding the lab through the CLIA certification process, feels "This is an immense step forward for GenWay Biotech, Inc. We are excited to begin accepting patient samples and performing revolutionary tests that may save patients lives and enhance their treatment by monitoring their condition with simple non-invasive blood tests." The GenWay team is looking forward to the future impact of the cancer biomarker tests they will offer. They have secured exclusive rights to the DR-70 test from AMDL and have secured several other biomarkers in the field of cancer diagnostics. Dr. Jill Dombrauckas GenWay Biotech


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):